Abstract P2-09-05: The potent anti-androgen enzalutamide demonstrates broad anti-tumour activity across all androgen receptor-positive triple-negative breast cancer subtypes
2011 ◽
Vol 121
(7)
◽
pp. 2750-2767
◽
Keyword(s):
2013 ◽
Vol 139
(6)
◽
pp. 905-914
◽
2017 ◽
Vol 18
(7)
◽
pp. 1505
◽